Revolutionising treatment of breast and prostate cancer

Wednesday, 25 October 2017

A free public lecture at the University of Adelaide will hear from world-leading experts in breast and prostate cancer about the latest research and the future directions of treatment for patients.

Transforming endocrine therapy for breast and prostate cancer will feature Dr Luke Selth and Dr Theresa Hickey from the Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide.

The event will be held on Wednesday 1 November, representing the crossover from Breast Cancer Awareness month (October) to the beginning of a major event on the prostate cancer fundraising calendar, Movember.

Breast cancer is predicted to become the most commonly diagnosed cancer in women in 2017, with one in every eight Australian women estimated to be diagnosed before their 85th birthday. Prostate cancer is also a major health issue in this country, with one in every seven men diagnosed with the disease before the age of 85.

Dr Selth and Dr Hickey will discuss how they leverage the similarities of breast and prostate cancer to make discoveries aimed at revolutionising the treatment of both diseases, by attempting to reprogram the hormone receptors that drive breast and prostate cancer.

WHAT: Executive Dean's Public Lecture Series: Transforming endocrine therapy for breast and prostate cancer by Dr Luke Selth and Dr Theresa Hickey
WHERE: G030 lecture theatre, Adelaide Health and Medical Sciences building, University of Adelaide, 57 North Terrace (next to SAHMRI, at the West End of North Terrace)
WHEN: 5.30–6.30pm Wednesday 1 November 2017
RSVP: FREE, all welcome – please register

Contact Details